跳至主要内容
临床试验/NL-OMON27174
NL-OMON27174暂停不适用

Assessment of Perinatal Outcome by uSe of Tocolysis in Early Labour: Nifedipine versus placebo in the treatment of preterm premature rupture of membranes.

Academic Medical Center (AMC)0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
120

研究概览

简要总结

ijman, Tobias AJ, et al. "Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor—APOSTEL IV trial." European Journal of Obstetrics & Gynecology and Reproductive Biology 205 (2016): 79-84.

研究设计

研究类型
Interventional

入排标准

入选标准

  • All women with a gestational age between 24+0/7 and 33+6/7 weeks with ruptured membranes without other signs of active labour are eligible for the trial.

排除标准

  • 1. Women with ≥3 contractions per 10 minutes;
  • 2. Woman with symptoms justifying start of tocolysis;

研究者

发起方
Academic Medical Center (AMC)

相似试验